Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV)

[1]  A. Wu,et al.  Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. , 1998, Medical care.

[2]  R. Chaisson,et al.  Clarithromycin Therapy for Bacteremic Mycobacterium avium Complex Disease , 1994, Annals of Internal Medicine.

[3]  The Status of Health in Demand Estimation , 1981 .

[4]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[5]  John E. Ware,et al.  Measuring Functioning and Well-Being , 1992 .

[6]  Lewis E. Kazis,et al.  Effect Sizes for Interpreting Changes in Health Status , 1989, Medical care.

[7]  J. Ware,et al.  Evaluating Translations of Health Status Questionnaires: Methods From the IQOLA Project , 1995, International Journal of Technology Assessment in Health Care.

[8]  K. Nott,et al.  Psychosocial vulnerability to stress: a study of HIV-positive homosexual men. , 1996, Journal of psychosomatic research.

[9]  B. Sha.  Combination Foscarnet and Ganciclovir Therapy vs. Monotherapy for the Treatment of Relapsed Cytomegalovirus Retinitis in Patients with AIDS: The Cytomegalovirus Retreatment Trial , 1996, Archives of ophthalmology.

[10]  P. Converse,et al.  The Quality of American Life: Perceptions, Evaluations, and Satisfactions , 1976 .

[11]  A. Wu,et al.  Measuring visual function and quality of life in patients with cytomegalovirus retinitis. Development of a questionnaire. Studies of Ocular Complication of AIDS Research Group. , 1996, Archives of ophthalmology.

[12]  J. Nunnally.  Psychometric Theory (2nd ed), New York: McGraw-Hill. , 1978 .

[13]  R M Kaplan,et al.  Validity of the Quality of Well-Being Scale for Persons With Human Immunodeficiency Virus Infection , 1995, Psychosomatic medicine.

[14]  K. Chan,et al.  Discriminant validity of the Medical Outcomes Study cognitive function scale in HIV disease patients , 1998, Quality of Life Research.

[15]  J. Catalan,et al.  Reliability and validity of an HIV-specific health-related quality-of-life measure for use with injecting drug users. , 1996, AIDS.

[16]  M. Testa,et al.  Methods for quality-of-life studies. , 1994, Annual review of public health.

[17]  M. Bullinger,et al.  HIV-Infektion und gesundheitsbezogene Lebensqualität: Psychometrische Prüfund der deutschsprachigen Version des «MOS-HIV»-Fragebogens zur Therapieerfolgskontrolle , 1994 .

[18]  Douglas D. Richman,et al.  The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection a double-blind, placebo-controlled trial , 1990 .

[19]  J. Verdejo Ortés.  [Cytomegalovirus retinitis in patients with AIDS]. , 1996, Revista clinica espanola.

[20]  J. Phair,et al.  Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS: The cytomegalovirus retreatment trial , 1996 .

[21]  D. Kanouse,et al.  Comparison of health-related quality of life in clinical trial and nonclinical trial human immunodeficiency virus-infected cohorts. , 1995, Medical care.

[22]  D A Revicki,et al.  Change in clinical status, health status, and health utility outcomes in HIV-infected patients. , 1995, Medical care.

[23]  D. Schade,et al.  Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial. , 1996, Annals of internal medicine.

[24]  J. Catalan,et al.  The reliability and validity of two HIV-specific health-related Quality-of-Life measures: a preliminary analysis. , 1993, AIDS.

[25]  A. Wu,et al.  Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection. , 1993, Journal of acquired immune deficiency syndromes.

[26]  P. Ganz,et al.  Assessing the quality of life of HIV infected persons: Clinical and descriptive information from studies with the hopes , 1994 .

[27]  Ware J.E.Jr.,et al.  THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .

[28]  A. Wu,et al.  The effect of mode of administration on Medical Outcomes Study health ratings and EuroQol scores in AIDS , 2004, Quality of Life Research.

[29]  A. Wu,et al.  Health status assessment. Completing the clinical database. , 1997 .

[30]  Albert Wu,et al.  Comparison of Three Regimens for Treatment of Mild to Moderate Pneumocystis carinii Pneumonia in Patients with AIDS: A Double-Blind, Randomized Trial of Oral Trimethoprim-Sulfamethoxazole, Dapsone-Trimethoprim, and Clindamycin-Primaquine , 1996, Annals of Internal Medicine.

[31]  A. Stewart,et al.  The MOS short-form general health survey. Reliability and validity in a patient population. , 1988, Medical care.

[32]  J. Singer,et al.  Estimating the effect of treatment on quality of life in the presence of missing data due to drop-out and death , 1998, Quality of Life Research.

[33]  W. Guerra.  Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter , 1991 .

[34]  A. Wu,et al.  The use of two measures of health-related quality of life in HIV-infected individuals: a cross-sectional comparison , 1996, Quality of Life Research.

[35]  M. Monga,et al.  Quality of life assessment in pregnant women with the human immunodeficiency virus , 1996, Obstetrics and gynecology.

[36]  P. Ganz,et al.  Assessing the needs and quality of life of patients with HIV infection: development of theHIVOverview ofProblems-EvaluationSystem (HOPES) , 1992, Quality of Life Research.

[37]  K. Motamedi.  The quality of American life , 1976 .

[38]  Quality of Life in PWAs , 1994 .

[39]  H. Rubin,et al.  A Health Status Questionnaire Using 30 Items From The Medical Outcomes Study: Preliminary Validation in Persons With Early HIV Infection , 1991, Medical care.

[40]  J. Sherrard,et al.  Pain in human immunodeficiency virus disease: a review , 1993, Pain.

[41]  J. Shea,et al.  SF-20 score and item distributions in a human immunodeficiency virus-seropositive sample. , 1996, Medical care.

[42]  A. Stewart,et al.  Measuring Functioning and Well-Being: The Medical Outcomes Study Approach , 1992 .